Key Takeaways Ulta Beauty's fragrance category rose double digits in Q2, reaching 12% of net sales.Growth came from gifting, exclusives, new launches, and expanded men's assortments.In-store conversion and brand events boosted premium and gift fragrance sell-through.Ulta Beauty, Inc.’s (ULTA) fragrance category delivered robust double-digit growth in the second quarter of fiscal 2025, emerging as the strongest-performing category for the period. Per the fiscal second-quarter earnings release, fragrance acco ...

We came across a bullish thesis on Protagonist Therapeutics, Inc. on BiotechBonanza’s Substack by AnotherBio. In this article, we will summarize the bulls’ thesis on PTGX. Protagonist Therapeutics, Inc.'s share was trading at $59.68 as of September 11th. PTGX’s trailing and forward P/E were 81.75 and 26.39 respectively according to Yahoo Finance. 10 Best Healthcare Dividend Stocks To Buy Protagonist Therapeutics (PTGX) presents a compelling investment case following strong clinical progress and underappr ...

Focus of Article: The focus of this two-part article is a very detailed analysis comparing Blackstone Secured Lending (NYSE:BXSL) to some of the company’s business development company (“BDC”) peers (all sector peers I currently fully cover). I am writing this two-part article due to the continued requests that such an analysis be specifically performed on BXSL and some of the company’s BDC peers at periodic intervals. For readers who just want the summarized conclusions/results, I would suggest to scroll do ...

Focus of Article: The focus of this two-part article is a very detailed analysis comparing Blackstone Secured Lending (NYSE:BXSL) to some of the company’s business development company (“BDC”) peers (all sector peers I currently fully cover). I am writing this two-part article due to the continued requests that such an analysis be specifically performed on BXSL and some of the company’s BDC peers at periodic intervals. For readers who just want the summarized conclusions/results, I would suggest to scroll do ...

The Ramsey Show/YouTube Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below. Tom called into The Ramsey Show in early August, sharing what he called “quite the financial mess.” The 30-year-old former commercial real estate analyst from New Jersey is swimming in debt with four mortgages, a car loan, and a credit card — all to the tune of more than $1.8 million in debt. Must Read Before being laid off seven months ago, Tom earned $130,000 annually in commerc ...

We came across a bullish thesis on ARS Pharmaceuticals, Inc. on Value Degen’s Substack’s Substack by Unemployed Value Degen. In this article, we will summarize the bulls’ thesis on SPRY. ARS Pharmaceuticals, Inc.'s share was trading at $10.15 as of September 11th. ARS Pharmaceuticals (ARS) is positioned in the epinephrine delivery market with its nasal spray, Neffy, supported by a portfolio of patents covering composition, formulation, dosage, delivery devices, and absorption-enhancing companion drugs, w ...

We came across a bullish thesis on Warner Bros. Discovery, Inc. on High Growth Investing’s Substack by Stefan Waldhauser. In this article, we will summarize the bulls’ thesis on WBD. Warner Bros. Discovery, Inc.'s share was trading at $16.17 as of September 11th. WBD’s trailing and forward P/E were 52.16 and 39.06 respectively according to Yahoo Finance. news, media, home, video, studio, broadcasting, broadcast, vod, tv, screen, vision, provider, isolated, satelite, display, theater, globalization, movie, ...

We came across a bullish thesis on Broadcom Inc. on X.com by Wiseman_Cap. In this article, we will summarize the bulls’ thesis on AVGO. Broadcom Inc.'s share was trading at $359.63 as of September 11th. AVGO’s trailing and forward P/E were 92.21 and 39.53 respectively according to Yahoo Finance. Broadcom Inc. (AVGO)'s CEO Is "A Tough Guy," Says Jim Cramer electronics-6055226_1280 Broadcom’s Ethernet products, which are increasingly used to scale both up and out connectivity. Scale-up unit volumes are cu ...

We came across a bullish thesis on DexCom, Inc. on Flyover Stocks Substack by Todd Wenning. In this article, we will summarize the bulls’ thesis on DXCM. DexCom, Inc.'s share was trading at $76.22 as of September 12th. DXCM’s trailing and forward P/E were 53.68 and 29.41 respectively according to Yahoo Finance. Best Diabetes Stocks to Buy Now DexCom (DXCM) is a leading provider of continuous glucose monitoring (CGM) devices, serving millions of people managing Type 1 and Type 2 diabetes, as well as indiv ...

Deutsche Bank supports the establishment of the Defence, Security and Resilience Bank (DSRB), an initiative to create a global state-backed defence bank to fund countries' rearmament, it said on Wedne... ...